Another poster posted these stock articles so I suggest you read the forum but you probably say it's IMU "paid" anyway, if you can't think for yourself this CN isn't like others than I don't now what to tell you. The CN and warrant is dependent on the clinical trial updates for VAXINIA and OASIS and CVI will make at least 3 bagger return on no risk. But, like I said, it will be bad for traders and ST if they dump on the re-rate due to clinical trial announcements so stuff them.
IMU will have enough data from VAXINIA, Azer-Cel and especially OASIS end of this year for BP to start be interested as Azer-Cel will be close to registrational clinical trial and both VAXINIA and OASIS would have demonstrate efficacy which is usually seen toward end of Ph2 clinical trial.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)